0 Commenti
0 condivisioni
129 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Parkinson’s Disorder Drugs Market: Trends, Forecast, and Competitive Landscape 2025 –2032Executive Summary Parkinson’s Disorder Drugs Market: Share, Size & Strategic Insights CAGR Value The global Parkinson’s disorder drugs market size was valued at USD 5.19 billion in 2024 and is expected to reach USD 13.70 billion by 2032, at a CAGR of 12.90% during the forecast period For an excellent outcome of Parkinson’s Disorder...0 Commenti 0 condivisioni 744 Views 0 Anteprima
-
North America Parkinson’s Disease Drug Market Size and Growth ForecastThe Parkinson’s disease drug market is entering a phase of steady transformation as pharmaceutical innovation, demographic shifts, and expanding diagnosis rates reshape the treatment landscape. Parkinson’s disease (PD) is a progressive neurodegenerative disorder that primarily affects movement, creating a long-term need for pharmacological therapy to manage symptoms and improve...0 Commenti 0 condivisioni 246 Views 0 Anteprima
-
Parkinson's Disease Rehabilitation: A Comprehensive Approach to Improving Daily FunctionUnderstanding Parkinson's Disease Parkinson's disease is a progressive neurological condition that primarily affects movement, but its impact can extend to speech, swallowing, sleep, mood, cognition, and everyday activities. Symptoms can vary considerably between individuals and may change as the condition progresses. Common motor symptoms include tremor, muscle stiffness, slowed movement,...0 Commenti 0 condivisioni 122 Views 0 Anteprima
-
Parkinson’s Disease Market Outlook: 6.3% CAGR Growth Through 2031According to a newly published market research report by 24LifeSciences, global Parkinson's Disease market was valued at USD 5.8 billion in 2024 and is projected to reach USD 8.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 20252031. Parkinson's Disease (PD), clinically recognized as a progressive neurodegenerative disorder, is...0 Commenti 0 condivisioni 178 Views 0 Anteprima
-
Parkinson’s Disease Therapeutics Market to Reach USD 10.12 Billion by 2032.The Global Parkinson’s disease therapeutics market is accelerating into a new era of scientific possibility and patient-centered innovation, with total valuation projected to climb from USD 5.46 Billion in 2023 to USD 10.12 Billion by 2032-a compound annual growth rate (CAGR) of 7.1% over the forecast period. This sustained expansion is driven by...0 Commenti 0 condivisioni 451 Views 0 Anteprima
-
Parkinson’s Disease Treatment Market Expands at 6.3% CAGR Through 2031According to a newly published market research report by 24LifeSciences, global Parkinson's Disease market was valued at USD 5.8 billion in 2024 and is projected to reach USD 8.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 20252031. Parkinson's Disease (PD), clinically recognized as...0 Commenti 0 condivisioni 177 Views 0 Anteprima
-
The Parkinson's Solution: How Parkinson's Disease Devices are Evolving with Advanced TechnologyParkinson's disease (PD) is a progressive neurodegenerative disorder that presents significant challenges for patients and their families. While medication is the mainstay of treatment, its effectiveness often diminishes over time, leading to the emergence of debilitating motor fluctuations and side effects. Parkinson's disease devices , particularly deep brain stimulation (DBS)...0 Commenti 0 condivisioni 66 Views 0 Anteprima
-
U.S. Blood-Based Biomarker for Parkinson’s Disease Market Projected to Grow at 19.6% CAGR Through 2034Polaris Market Research has published insightful research on U.S. Blood-Based Biomarker For Parkinson’s Disease Market. The research report offers an in-depth analysis of the market, covering all the major aspects, including market size, market share, growth drivers, and key trends. Besides, a thorough assessment of the annual forecast, strategies, and potential roadmaps has been...0 Commenti 0 condivisioni 78 Views 0 Anteprima
-
Wolff Parkinson White Syndrome Market Advances Through Breakthrough Cardiac Treatment Technologies" According to the latest report published by Data Bridge Market Research, the Wolff Parkinson White Syndrome Market CAGR Value The Wolff Parkinson white syndrome market was valued at USD 1,047.19 million in 2022 and is expected to reach USD 1,466.57 million by 2030, registering a CAGR of 4.30% during the forecast period of 2023-2030. Wolff Parkinson White Syndrome Marketing...0 Commenti 0 condivisioni 156 Views 0 Anteprima
-
Wolff Parkinson White Syndrome Market Set to Expand with Advances in Cardiac Ablation Therapies" According to the latest report published by Data Bridge Market Research, the Wolff Parkinson White Syndrome Market CAGR Value The Wolff Parkinson white syndrome market was valued at USD 1,047.19 million in 2022 and is expected to reach USD 1,466.57 million by 2030, registering a CAGR of 4.30% during the forecast period of 2023-2030. The persuasive Wolff Parkinson White...0 Commenti 0 condivisioni 60 Views 0 Anteprima
-
Acetylcarnitine Market: Global Outlook & Market DynamicsIntrospective Market Research, a global provider of specialized chemical and pharmaceutical market intelligence, today released its comprehensive analysis of the Global Acetylcarnitine Market. Acetylcarnitine (ALCAR), a crucial derivative of the amino acid carnitine, plays a vital role in mitochondrial energy generation and is highly valued for its antioxidant and neuroprotective properties....0 Commenti 0 condivisioni 4K Views 0 Anteprima
-
Neurological Biomarkers Market Outlook for Biomarker-Based TherapeuticsThe neurological biomarkers market is entering a transformative phase as healthcare and pharmaceutical research increasingly seek faster, more precise, and less invasive ways to understand neurological disorders. Biomarkers are becoming important not only for diagnosis but also for determining disease progression, evaluating treatment response, supporting patient stratification, and improving...0 Commenti 0 condivisioni 24 Views 0 Anteprima
Pagine in Evidenza
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali